HEADER HYDROLASE 21-APR-13 4K9S TITLE PEPTIDOGLYCAN O-ACETYLESTERASE IN ACTION, SETMET COMPND MOL_ID: 1; COMPND 2 MOLECULE: GDSL-LIKE LIPASE/ACYLHYDROLASE FAMILY PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: NEISSERIA MENINGITIDIS; SOURCE 3 ORGANISM_TAXID: 1095679; SOURCE 4 STRAIN: MC58; SOURCE 5 GENE: NEISSERIA MENINGITIDIS, NM4119_1198; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX 4TI KEYWDS ALPHA/BETA FOLD, PEPTIDOGLYCAN HYDROLASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.H.WILLIAMS,I.GOMPERT BONECA REVDAT 2 22-OCT-14 4K9S 1 JRNL REVDAT 1 03-SEP-14 4K9S 0 JRNL AUTH A.H.WILLIAMS,F.J.VEYRIER,M.BONIS,Y.MICHAUD,B.RAYNAL, JRNL AUTH 2 M.K.TAHA,S.W.WHITE,A.HAOUZ,I.G.BONECA JRNL TITL VISUALIZATION OF A SUBSTRATE-INDUCED PRODUCTIVE CONFORMATION JRNL TITL 2 OF THE CATALYTIC TRIAD OF THE NEISSERIA MENINGITIDIS JRNL TITL 3 PEPTIDOGLYCAN O-ACETYLESTERASE REVEALS MECHANISTIC JRNL TITL 4 CONSERVATION IN SGNH ESTERASE FAMILY MEMBERS. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 70 2631 2014 JRNL REFN ISSN 0907-4449 JRNL PMID 25286847 JRNL DOI 10.1107/S1399004714016770 REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.2_1309) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE- REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO, REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH, REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER REMARK 3 : ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1516 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.4159 - 5.1869 1.00 2827 150 0.1766 0.2376 REMARK 3 2 5.1869 - 4.1183 1.00 2693 142 0.1454 0.2153 REMARK 3 3 4.1183 - 3.5981 0.99 2661 140 0.1500 0.2534 REMARK 3 4 3.5981 - 3.2693 0.99 2641 139 0.1613 0.2659 REMARK 3 5 3.2693 - 3.0350 0.99 2644 140 0.1763 0.2715 REMARK 3 6 3.0350 - 2.8562 0.99 2625 138 0.1935 0.2876 REMARK 3 7 2.8562 - 2.7131 0.99 2598 137 0.1914 0.3092 REMARK 3 8 2.7131 - 2.5951 0.99 2602 137 0.1826 0.2704 REMARK 3 9 2.5951 - 2.4952 0.99 2584 136 0.1922 0.3059 REMARK 3 10 2.4952 - 2.4091 0.99 2593 136 0.2087 0.2947 REMARK 3 11 2.4091 - 2.3338 0.88 2285 121 0.2282 0.3320 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 5433 REMARK 3 ANGLE : 1.239 7369 REMARK 3 CHIRALITY : 0.080 806 REMARK 3 PLANARITY : 0.004 962 REMARK 3 DIHEDRAL : 15.552 1943 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4K9S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAY-13. REMARK 100 THE RCSB ID CODE IS RCSB079070. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 2673 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.334 REMARK 200 RESOLUTION RANGE LOW (A) : 40.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.510 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES PH 7.5 10-40% PEG 10000 REMARK 280 , VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.09400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.95350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.53450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.95350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.09400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.53450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 19 REMARK 465 SER A 20 REMARK 465 LEU A 21 REMARK 465 PRO A 22 REMARK 465 VAL A 23 REMARK 465 ALA A 24 REMARK 465 SER A 25 REMARK 465 VAL A 26 REMARK 465 SER A 27 REMARK 465 LEU A 28 REMARK 465 ASP A 29 REMARK 465 THR A 30 REMARK 465 VAL A 31 REMARK 465 THR A 32 REMARK 465 VAL A 33 REMARK 465 SER A 34 REMARK 465 PRO A 35 REMARK 465 SER A 36 REMARK 465 ALA A 37 REMARK 465 PRO A 38 REMARK 465 TYR A 39 REMARK 465 THR A 40 REMARK 465 ASP A 41 REMARK 465 THR A 42 REMARK 465 ASN A 43 REMARK 465 GLY A 44 REMARK 465 ALA A 394 REMARK 465 ILE A 395 REMARK 465 ARG A 396 REMARK 465 GLN A 397 REMARK 465 GLY B 19 REMARK 465 SER B 20 REMARK 465 LEU B 21 REMARK 465 PRO B 22 REMARK 465 VAL B 23 REMARK 465 ALA B 24 REMARK 465 SER B 25 REMARK 465 VAL B 26 REMARK 465 SER B 27 REMARK 465 LEU B 28 REMARK 465 ASP B 29 REMARK 465 THR B 30 REMARK 465 VAL B 31 REMARK 465 THR B 32 REMARK 465 VAL B 33 REMARK 465 SER B 34 REMARK 465 PRO B 35 REMARK 465 SER B 36 REMARK 465 ALA B 37 REMARK 465 PRO B 38 REMARK 465 TYR B 39 REMARK 465 THR B 40 REMARK 465 ASP B 41 REMARK 465 THR B 42 REMARK 465 ASN B 43 REMARK 465 GLY B 44 REMARK 465 ALA B 394 REMARK 465 ILE B 395 REMARK 465 ARG B 396 REMARK 465 GLN B 397 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN B 51 O HOH B 528 2.14 REMARK 500 OE1 GLN A 282 O HOH A 553 2.16 REMARK 500 O HOH B 549 O HOH B 563 2.16 REMARK 500 NE2 GLN B 255 O HOH B 440 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 425 O HOH B 453 4556 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 79 -144.90 -97.09 REMARK 500 ASP A 159 -95.58 -108.48 REMARK 500 ILE A 161 -17.94 -152.56 REMARK 500 ALA A 162 -8.09 59.62 REMARK 500 ALA A 176 -82.25 -42.11 REMARK 500 THR A 199 -157.91 -148.73 REMARK 500 MSE A 232 77.57 -107.91 REMARK 500 THR A 312 51.51 -107.34 REMARK 500 TYR B 49 -45.45 83.82 REMARK 500 ASN B 51 -32.16 106.18 REMARK 500 ASP B 79 -149.53 -108.17 REMARK 500 ASP B 85 -0.53 76.29 REMARK 500 ASP B 159 -120.03 -87.66 REMARK 500 ILE B 161 128.40 142.28 REMARK 500 ALA B 162 -157.95 -92.55 REMARK 500 SER B 163 -137.29 -81.81 REMARK 500 MSE B 232 79.95 -115.97 REMARK 500 TYR B 265 -168.32 -129.87 REMARK 500 VAL B 315 -51.42 58.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL B 315 CYS B 316 149.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 TYR B 49 24.2 L L OUTSIDE RANGE REMARK 500 ASN B 51 21.2 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 413 DISTANCE = 5.75 ANGSTROMS REMARK 525 HOH B 411 DISTANCE = 5.07 ANGSTROMS REMARK 525 HOH B 506 DISTANCE = 5.18 ANGSTROMS REMARK 525 HOH B 575 DISTANCE = 5.43 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4K3U RELATED DB: PDB REMARK 900 RELATED ID: 4K40 RELATED DB: PDB REMARK 900 RELATED ID: 4K7J RELATED DB: PDB DBREF 4K9S A 21 397 UNP L5SU74 L5SU74_NEIME 21 397 DBREF 4K9S B 21 397 UNP L5SU74 L5SU74_NEIME 21 397 SEQADV 4K9S GLY A 19 UNP L5SU74 EXPRESSION TAG SEQADV 4K9S SER A 20 UNP L5SU74 EXPRESSION TAG SEQADV 4K9S GLY B 19 UNP L5SU74 EXPRESSION TAG SEQADV 4K9S SER B 20 UNP L5SU74 EXPRESSION TAG SEQRES 1 A 379 GLY SER LEU PRO VAL ALA SER VAL SER LEU ASP THR VAL SEQRES 2 A 379 THR VAL SER PRO SER ALA PRO TYR THR ASP THR ASN GLY SEQRES 3 A 379 LEU LEU THR ASP TYR GLY ASN ALA SER ALA SER PRO TRP SEQRES 4 A 379 MSE LYS LYS LEU GLN SER VAL ALA GLN GLY SER GLY GLU SEQRES 5 A 379 THR PHE ARG ILE LEU GLN ILE GLY ASP SER HIS THR ALA SEQRES 6 A 379 GLY ASP PHE PHE THR ASP SER LEU ARG LYS ARG LEU GLN SEQRES 7 A 379 LYS THR TRP GLY ASP GLY GLY ILE GLY TRP VAL TYR PRO SEQRES 8 A 379 ALA ASN VAL LYS GLY GLN ARG MSE ALA ALA VAL ARG HIS SEQRES 9 A 379 ASN GLY ASN TRP GLN SER LEU THR SER ARG ASN ASN THR SEQRES 10 A 379 GLY ASP PHE PRO LEU GLY GLY ILE LEU ALA HIS THR GLY SEQRES 11 A 379 SER GLY GLY SER MSE THR LEU THR ALA SER ASP GLY ILE SEQRES 12 A 379 ALA SER LYS GLN ARG VAL SER LEU PHE ALA LYS PRO LEU SEQRES 13 A 379 LEU ALA GLU GLN THR LEU THR VAL ASN GLY ASN THR VAL SEQRES 14 A 379 SER ALA ASN GLY GLY GLY TRP GLN VAL LEU ASP THR GLY SEQRES 15 A 379 ALA ALA LEU PRO LEU THR ILE HIS THR GLU MSE PRO TRP SEQRES 16 A 379 ASP ILE GLY PHE ILE ASN ILE GLU ASN PRO ALA GLY GLY SEQRES 17 A 379 ILE THR VAL SER ALA MSE GLY ILE ASN GLY ALA GLN LEU SEQRES 18 A 379 THR GLN TRP SER LYS TRP ARG ALA ASP ARG MSE ASN ASP SEQRES 19 A 379 LEU ALA GLN THR GLY ALA ASP LEU VAL ILE LEU SER TYR SEQRES 20 A 379 GLY THR ASN GLU ALA PHE ASN ASN ASN ILE ASP ILE ALA SEQRES 21 A 379 ASP THR GLU GLN LYS TRP LEU ASP THR VAL ARG GLN ILE SEQRES 22 A 379 ARG ASP SER LEU PRO ALA ALA GLY ILE LEU ILE ILE GLY SEQRES 23 A 379 ALA PRO GLU SER LEU LYS ASN THR LEU GLY VAL CYS GLY SEQRES 24 A 379 THR ARG PRO VAL ARG LEU THR GLU VAL GLN GLN MSE GLN SEQRES 25 A 379 ARG ARG VAL ALA ARG GLN GLY GLN THR MSE PHE TRP SER SEQRES 26 A 379 TRP GLN ASN ALA MSE GLY GLY ILE CYS SER MSE LYS ASN SEQRES 27 A 379 TRP LEU ASN GLN GLY TRP ALA ALA LYS ASP GLY VAL HIS SEQRES 28 A 379 PHE SER ALA LYS GLY TYR ARG ARG ALA ALA GLU MSE LEU SEQRES 29 A 379 ALA ASP SER LEU GLU GLU LEU VAL ARG SER ALA ALA ILE SEQRES 30 A 379 ARG GLN SEQRES 1 B 379 GLY SER LEU PRO VAL ALA SER VAL SER LEU ASP THR VAL SEQRES 2 B 379 THR VAL SER PRO SER ALA PRO TYR THR ASP THR ASN GLY SEQRES 3 B 379 LEU LEU THR ASP TYR GLY ASN ALA SER ALA SER PRO TRP SEQRES 4 B 379 MSE LYS LYS LEU GLN SER VAL ALA GLN GLY SER GLY GLU SEQRES 5 B 379 THR PHE ARG ILE LEU GLN ILE GLY ASP SER HIS THR ALA SEQRES 6 B 379 GLY ASP PHE PHE THR ASP SER LEU ARG LYS ARG LEU GLN SEQRES 7 B 379 LYS THR TRP GLY ASP GLY GLY ILE GLY TRP VAL TYR PRO SEQRES 8 B 379 ALA ASN VAL LYS GLY GLN ARG MSE ALA ALA VAL ARG HIS SEQRES 9 B 379 ASN GLY ASN TRP GLN SER LEU THR SER ARG ASN ASN THR SEQRES 10 B 379 GLY ASP PHE PRO LEU GLY GLY ILE LEU ALA HIS THR GLY SEQRES 11 B 379 SER GLY GLY SER MSE THR LEU THR ALA SER ASP GLY ILE SEQRES 12 B 379 ALA SER LYS GLN ARG VAL SER LEU PHE ALA LYS PRO LEU SEQRES 13 B 379 LEU ALA GLU GLN THR LEU THR VAL ASN GLY ASN THR VAL SEQRES 14 B 379 SER ALA ASN GLY GLY GLY TRP GLN VAL LEU ASP THR GLY SEQRES 15 B 379 ALA ALA LEU PRO LEU THR ILE HIS THR GLU MSE PRO TRP SEQRES 16 B 379 ASP ILE GLY PHE ILE ASN ILE GLU ASN PRO ALA GLY GLY SEQRES 17 B 379 ILE THR VAL SER ALA MSE GLY ILE ASN GLY ALA GLN LEU SEQRES 18 B 379 THR GLN TRP SER LYS TRP ARG ALA ASP ARG MSE ASN ASP SEQRES 19 B 379 LEU ALA GLN THR GLY ALA ASP LEU VAL ILE LEU SER TYR SEQRES 20 B 379 GLY THR ASN GLU ALA PHE ASN ASN ASN ILE ASP ILE ALA SEQRES 21 B 379 ASP THR GLU GLN LYS TRP LEU ASP THR VAL ARG GLN ILE SEQRES 22 B 379 ARG ASP SER LEU PRO ALA ALA GLY ILE LEU ILE ILE GLY SEQRES 23 B 379 ALA PRO GLU SER LEU LYS ASN THR LEU GLY VAL CYS GLY SEQRES 24 B 379 THR ARG PRO VAL ARG LEU THR GLU VAL GLN GLN MSE GLN SEQRES 25 B 379 ARG ARG VAL ALA ARG GLN GLY GLN THR MSE PHE TRP SER SEQRES 26 B 379 TRP GLN ASN ALA MSE GLY GLY ILE CYS SER MSE LYS ASN SEQRES 27 B 379 TRP LEU ASN GLN GLY TRP ALA ALA LYS ASP GLY VAL HIS SEQRES 28 B 379 PHE SER ALA LYS GLY TYR ARG ARG ALA ALA GLU MSE LEU SEQRES 29 B 379 ALA ASP SER LEU GLU GLU LEU VAL ARG SER ALA ALA ILE SEQRES 30 B 379 ARG GLN MODRES 4K9S MSE A 58 MET SELENOMETHIONINE MODRES 4K9S MSE A 117 MET SELENOMETHIONINE MODRES 4K9S MSE A 153 MET SELENOMETHIONINE MODRES 4K9S MSE A 211 MET SELENOMETHIONINE MODRES 4K9S MSE A 232 MET SELENOMETHIONINE MODRES 4K9S MSE A 250 MET SELENOMETHIONINE MODRES 4K9S MSE A 329 MET SELENOMETHIONINE MODRES 4K9S MSE A 340 MET SELENOMETHIONINE MODRES 4K9S MSE A 348 MET SELENOMETHIONINE MODRES 4K9S MSE A 354 MET SELENOMETHIONINE MODRES 4K9S MSE A 381 MET SELENOMETHIONINE MODRES 4K9S MSE B 58 MET SELENOMETHIONINE MODRES 4K9S MSE B 117 MET SELENOMETHIONINE MODRES 4K9S MSE B 153 MET SELENOMETHIONINE MODRES 4K9S MSE B 211 MET SELENOMETHIONINE MODRES 4K9S MSE B 232 MET SELENOMETHIONINE MODRES 4K9S MSE B 250 MET SELENOMETHIONINE MODRES 4K9S MSE B 329 MET SELENOMETHIONINE MODRES 4K9S MSE B 340 MET SELENOMETHIONINE MODRES 4K9S MSE B 348 MET SELENOMETHIONINE MODRES 4K9S MSE B 354 MET SELENOMETHIONINE MODRES 4K9S MSE B 381 MET SELENOMETHIONINE HET MSE A 58 8 HET MSE A 117 8 HET MSE A 153 8 HET MSE A 211 8 HET MSE A 232 8 HET MSE A 250 8 HET MSE A 329 8 HET MSE A 340 8 HET MSE A 348 8 HET MSE A 354 8 HET MSE A 381 8 HET MSE B 58 8 HET MSE B 117 8 HET MSE B 153 8 HET MSE B 211 8 HET MSE B 232 8 HET MSE B 250 8 HET MSE B 329 8 HET MSE B 340 8 HET MSE B 348 8 HET MSE B 354 8 HET MSE B 381 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 22(C5 H11 N O2 SE) FORMUL 3 HOH *396(H2 O) HELIX 1 1 ASN A 51 ALA A 54 5 4 HELIX 2 2 SER A 55 GLN A 66 1 12 HELIX 3 3 ASP A 79 GLY A 84 1 6 HELIX 4 4 ASP A 85 GLY A 100 1 16 HELIX 5 5 GLN A 238 TRP A 245 5 8 HELIX 6 6 ARG A 246 ALA A 247 5 2 HELIX 7 7 ASP A 248 THR A 256 1 9 HELIX 8 8 GLY A 266 PHE A 271 1 6 HELIX 9 9 ASP A 276 LEU A 295 1 20 HELIX 10 10 ARG A 322 GLY A 337 1 16 HELIX 11 11 TRP A 344 GLY A 349 1 6 HELIX 12 12 SER A 353 GLN A 360 1 8 HELIX 13 13 SER A 371 SER A 392 1 22 HELIX 14 14 ASN B 51 ALA B 54 5 4 HELIX 15 15 SER B 55 GLY B 67 1 13 HELIX 16 16 ASP B 79 GLY B 84 1 6 HELIX 17 17 ASP B 85 GLY B 100 1 16 HELIX 18 18 GLN B 238 TRP B 245 5 8 HELIX 19 19 ASP B 248 THR B 256 1 9 HELIX 20 20 GLY B 266 PHE B 271 1 6 HELIX 21 21 ASP B 276 LEU B 295 1 20 HELIX 22 22 ARG B 322 GLY B 337 1 16 HELIX 23 23 TRP B 344 GLY B 349 1 6 HELIX 24 24 SER B 353 GLN B 360 1 8 HELIX 25 25 SER B 371 ALA B 393 1 23 SHEET 1 A 6 LEU A 46 ASP A 48 0 SHEET 2 A 6 MSE A 340 SER A 343 -1 O PHE A 341 N THR A 47 SHEET 3 A 6 GLY A 299 GLY A 304 1 N ILE A 302 O MSE A 340 SHEET 4 A 6 LEU A 260 SER A 264 1 N VAL A 261 O GLY A 299 SHEET 5 A 6 THR A 71 GLY A 78 1 N ILE A 77 O ILE A 262 SHEET 6 A 6 GLY A 226 GLY A 233 1 O SER A 230 N ILE A 74 SHEET 1 B 4 GLY A 105 VAL A 107 0 SHEET 2 B 4 TRP A 213 GLU A 221 -1 O ILE A 218 N VAL A 107 SHEET 3 B 4 ILE A 143 HIS A 146 -1 N ALA A 145 O ILE A 215 SHEET 4 B 4 GLN A 127 THR A 130 -1 N LEU A 129 O LEU A 144 SHEET 1 C 4 GLY A 105 VAL A 107 0 SHEET 2 C 4 TRP A 213 GLU A 221 -1 O ILE A 218 N VAL A 107 SHEET 3 C 4 GLN A 165 PRO A 173 -1 N SER A 168 O ASN A 219 SHEET 4 C 4 GLN A 195 ALA A 201 -1 O ALA A 201 N GLN A 165 SHEET 1 D 5 VAL A 120 GLY A 124 0 SHEET 2 D 5 GLY A 151 ALA A 157 -1 O THR A 156 N ARG A 121 SHEET 3 D 5 LEU A 205 THR A 209 -1 O ILE A 207 N MSE A 153 SHEET 4 D 5 THR A 179 VAL A 182 -1 N THR A 181 O HIS A 208 SHEET 5 D 5 ASN A 185 SER A 188 -1 O VAL A 187 N LEU A 180 SHEET 1 E 6 LEU B 46 THR B 47 0 SHEET 2 E 6 MSE B 340 SER B 343 -1 O PHE B 341 N THR B 47 SHEET 3 E 6 GLY B 299 GLY B 304 1 N ILE B 300 O MSE B 340 SHEET 4 E 6 LEU B 260 SER B 264 1 N VAL B 261 O GLY B 299 SHEET 5 E 6 THR B 71 GLY B 78 1 N LEU B 75 O ILE B 262 SHEET 6 E 6 GLY B 226 GLY B 233 1 O THR B 228 N ILE B 74 SHEET 1 F 4 GLY B 103 VAL B 107 0 SHEET 2 F 4 TRP B 213 GLU B 221 -1 O ILE B 218 N VAL B 107 SHEET 3 F 4 ILE B 143 HIS B 146 -1 N ALA B 145 O ILE B 215 SHEET 4 F 4 GLN B 127 THR B 130 -1 N GLN B 127 O HIS B 146 SHEET 1 G 4 GLY B 103 VAL B 107 0 SHEET 2 G 4 TRP B 213 GLU B 221 -1 O ILE B 218 N VAL B 107 SHEET 3 G 4 LYS B 164 PRO B 173 -1 N SER B 168 O ASN B 219 SHEET 4 G 4 GLN B 195 ALA B 202 -1 O GLN B 195 N ALA B 171 SHEET 1 H 5 VAL B 120 GLY B 124 0 SHEET 2 H 5 GLY B 151 ALA B 157 -1 O THR B 156 N ARG B 121 SHEET 3 H 5 LEU B 205 THR B 209 -1 O ILE B 207 N MSE B 153 SHEET 4 H 5 THR B 179 VAL B 182 -1 N THR B 181 O HIS B 208 SHEET 5 H 5 ASN B 185 SER B 188 -1 O VAL B 187 N LEU B 180 LINK C TRP A 57 N MSE A 58 1555 1555 1.32 LINK C MSE A 58 N LYS A 59 1555 1555 1.33 LINK C ARG A 116 N MSE A 117 1555 1555 1.33 LINK C MSE A 117 N ALA A 118 1555 1555 1.33 LINK C SER A 152 N MSE A 153 1555 1555 1.33 LINK C MSE A 153 N THR A 154 1555 1555 1.33 LINK C GLU A 210 N MSE A 211 1555 1555 1.33 LINK C MSE A 211 N PRO A 212 1555 1555 1.35 LINK C ALA A 231 N MSE A 232 1555 1555 1.33 LINK C MSE A 232 N GLY A 233 1555 1555 1.32 LINK C ARG A 249 N MSE A 250 1555 1555 1.34 LINK C MSE A 250 N ASN A 251 1555 1555 1.33 LINK C GLN A 328 N MSE A 329 1555 1555 1.32 LINK C MSE A 329 N GLN A 330 1555 1555 1.34 LINK C THR A 339 N MSE A 340 1555 1555 1.33 LINK C MSE A 340 N PHE A 341 1555 1555 1.33 LINK C ALA A 347 N MSE A 348 1555 1555 1.33 LINK C MSE A 348 N GLY A 349 1555 1555 1.33 LINK C SER A 353 N MSE A 354 1555 1555 1.33 LINK C MSE A 354 N LYS A 355 1555 1555 1.33 LINK C GLU A 380 N MSE A 381 1555 1555 1.33 LINK C MSE A 381 N LEU A 382 1555 1555 1.33 LINK C TRP B 57 N MSE B 58 1555 1555 1.32 LINK C MSE B 58 N LYS B 59 1555 1555 1.34 LINK C ARG B 116 N MSE B 117 1555 1555 1.34 LINK C MSE B 117 N ALA B 118 1555 1555 1.32 LINK C SER B 152 N MSE B 153 1555 1555 1.33 LINK C MSE B 153 N THR B 154 1555 1555 1.33 LINK C GLU B 210 N MSE B 211 1555 1555 1.33 LINK C MSE B 211 N PRO B 212 1555 1555 1.34 LINK C ALA B 231 N MSE B 232 1555 1555 1.34 LINK C MSE B 232 N GLY B 233 1555 1555 1.32 LINK C ARG B 249 N MSE B 250 1555 1555 1.34 LINK C MSE B 250 N ASN B 251 1555 1555 1.33 LINK C GLN B 328 N MSE B 329 1555 1555 1.32 LINK C MSE B 329 N GLN B 330 1555 1555 1.33 LINK C THR B 339 N MSE B 340 1555 1555 1.33 LINK C MSE B 340 N PHE B 341 1555 1555 1.32 LINK C ALA B 347 N MSE B 348 1555 1555 1.33 LINK C MSE B 348 N GLY B 349 1555 1555 1.33 LINK C SER B 353 N MSE B 354 1555 1555 1.33 LINK C MSE B 354 N LYS B 355 1555 1555 1.33 LINK C GLU B 380 N MSE B 381 1555 1555 1.33 LINK C MSE B 381 N LEU B 382 1555 1555 1.33 CISPEP 1 LEU A 203 PRO A 204 0 2.71 CISPEP 2 GLY A 317 THR A 318 0 0.81 CISPEP 3 ASP B 48 TYR B 49 0 15.34 CISPEP 4 GLY B 50 ASN B 51 0 -1.77 CISPEP 5 GLY B 193 TRP B 194 0 -6.48 CISPEP 6 LEU B 203 PRO B 204 0 3.23 CISPEP 7 LEU B 313 GLY B 314 0 -7.05 CISPEP 8 CYS B 316 GLY B 317 0 18.09 CRYST1 72.188 79.069 123.907 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013853 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012647 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008071 0.00000